Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine
Condition: Poliomyelitis Intervention: Biological: bOPV and nOPV2 Sponsors: Fidec Corporation; Bill and Melinda Gates Foundation Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials